There are more than 1 billion doses of vaccination in the world, Which countries are far ahead?
As of the end of April, about 7.3% of the world’s population had received at least one dose of the new crown vaccine. But scientists say that if the epidemic is to be fully controlled, more than 75% of the world’s population needs to be vaccinated.
The global immunization of the new crown vaccine has exceeded the 1 billion dose mark, and only four months have passed since the WHO approved the first emergency vaccine and the United Kingdom and the United States began full vaccinations. Researchers believe that the rate of inoculation of the new crown vaccine is amazing, but the uneven distribution of vaccines also reveals inequality across the world.
“This is an unprecedented scientific achievement that exceeds everyone’s imagination. Within 16 months of the identification of a new virus, we have completed up to 10 different vaccines from different production countries using different technologies. 100 million doses of vaccination.” said Soumya Swaminathan, the chief scientist of the WHO based in Geneva, Switzerland.
As of April 27, 570 million people had received 1.06 billion doses of the vaccine, which means that about 7.3% of the global population of 7.79 billion people had received at least one dose. But scientists also said that if the epidemic is to be fully controlled, more than 75% of the world’s population needs to be vaccinated.
Whether it is the uneven distribution of vaccines within a country or between different countries, it will threaten the speed at which we can achieve this goal. “We can develop a variety of vaccines in a short period of time and complete 1 billion doses. This is undoubtedly a remarkable achievement, but this process has also exacerbated global inequality.” Deputy Director of Innovation, Duke Global Health Research Center, North Carolina Krishna Udayakumar said.
Approximately 3/4 of the vaccines have only gone to ten countries. The vaccines distributed by China and the United States account for nearly half of all vaccines, and only 2% of the vaccines are available on the entire African continent.
Ensuring global vaccine equality in the fight against the epidemic is a matter of self-interest for high-income countries, said Peter Hotez, a vaccine scientist at Baylor College of Medicine in Texas. “It is impossible to overcome the epidemic by vaccinating all employees in only a dozen countries,” he said. “If we want to save lives and restore the global economy, we must make vaccines available in places like Myanmar and Papua New Guinea.” Source: Our World in Data